GlassScriptPhysician profile
Terence L Chen
NPI 1720180946
$15,125.77
in general payments reported to CMS, 2019-2025
12 companies · $1,532 in 2025
The $1,532 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,406 · 2020: $1,563 · 2021: $5,408 · 2022: $2,327 · 2023: $1,605 · 2024: $1,285 · 2025: $1,532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,421.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,421.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $9,816.50 | 2019-2025 | Quartex, Excelsiusgps Robotic Navigation System, Creo |
| Alphatec Spine, INC | $2,970.58 | 2021-2022 | |
| Medtronic USA, INC. | $1,562.55 | 2020 | |
| Ucb, INC. | $320.26 | 2021-2025 | Briviact |
| Portola Pharmaceuticals, LLC | $132.30 | 2019 | |
| Cerapedics INC. | $80.17 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Providence Medical Technology, INC. | $62.16 | 2024 | |
| Medtronic, INC. | $51.56 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $49.80 | 2023-2024 | Andexxa |
| Nevro Corp. | $34.48 | 2024 | Senza |
| Aesculap, INC. | $24.34 | 2022 | |
| Arteriocyte Medical Systems, INC. | $21.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terence Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.